Telehealth Glaucoma Screening Trial Targets High-Risk Populations — Novel OCT-Based Detection Strategy for Underserved Communities

References

1. 1.Gupta, P., Zhao, D., Guallar, E., Ko, F., Boland, M. V., & Friedman, D. S. (2016). Prevalence of glaucoma in the United States: the 2005-2008 National Health and Nutrition Examination Survey. Investigative Ophthalmology & Visual Science, 57(6), 2905-2913. https://doi.org/10.1167/iovs.16-19581
2. 2.Rathi, S., Andrews, C. A., Greenfield, D. S., & Stein, J. D. (2020). Travel burden and clinical presentation in patients with glaucoma. Ophthalmology, 127(3), 362-369. https://doi.org/10.1016/j.ophtha.2019.09.024
3. 3.Tham, Y. C., Li, X., Wong, T. Y., Quigley, H. A., Aung, T., & Cheng, C. Y. (2014). Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology, 121(11), 2081-2090. https://doi.org/10.1016/j.ophtha.2014.05.013
4. 4.University of California, San Francisco. (2024). Novel Telehealth Technologies to Detect and Manage Glaucoma and Vision-threatening Eye Diseases in High-risk Populations. ClinicalTrials.gov. NCT06854198. https://clinicaltrials.gov/study/NCT06854198
5. 5.Weinreb, R. N., Aung, T., & Medeiros, F. A. (2014). The pathophysiology and treatment of glaucoma: a review. JAMA, 311(18), 1901-1911. https://doi.org/10.1001/jama.2014.3192